Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic neurons in the substantia nigra impacting the functioning of basal ganglia-thalamocortical circuits. The precise role played by the thalamus is unknown, despite its critical role in the functioning of the cerebral cortex, and the abnormal neuronal activity of the structure in PD. Our objective was to more clearly elucidate how functional connectivity and morphology of the thalamus are impacted in PD (n = 32) compared to Controls (n = 20). To investigate functional connectivity of the thalamus we subdivided the structure into two important regions-of-interest, the first with putative connections to the motor cortices and the second with putat...
Background: Resting-state functional magnetic resonance imaging (fMRI) studies have demonstrated tha...
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder due to loss of dopamine produc...
Parkinson’s disease patients present with the highest risk of dementia development. The thalamus, i...
Parkinson\u27s disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminer...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...
Parkinson’s disease (PD) affects 2–3% of the population over the age of 65 with loss of dopaminergic...
Parkinson disease (PD) is the second most common neurodegenerative disorder in the world, directly a...
International audienceReduced dopamine input to cortical and subcortical brain structures, particula...
Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity an...
Although the diagnosis of Parkinson's disease (PD) remains anchored around the cardinal motor sympto...
Abstract Background Recent pathological studies have suggested that thalamic degeneration may repres...
Parkinson’s disease (PD) is a common, disabling, neurodegenerative disease characterised by three co...
Objective: Visual hallucinations are common in Parkinson’s disease (PD) and associated with worse ...
Parkinson’s disease (PD) is primarily associated with two dominant features: cardinal motor symptoms...
Background: Resting-state functional magnetic resonance imaging (fMRI) studies have demonstrated tha...
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder due to loss of dopamine produc...
Parkinson’s disease patients present with the highest risk of dementia development. The thalamus, i...
Parkinson\u27s disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminer...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...
Parkinson’s disease (PD) affects 2–3% of the population over the age of 65 with loss of dopaminergic...
Parkinson disease (PD) is the second most common neurodegenerative disorder in the world, directly a...
International audienceReduced dopamine input to cortical and subcortical brain structures, particula...
Introduction: The study aim was to identify longitudinal abnormalities of functional connectivity an...
Although the diagnosis of Parkinson's disease (PD) remains anchored around the cardinal motor sympto...
Abstract Background Recent pathological studies have suggested that thalamic degeneration may repres...
Parkinson’s disease (PD) is a common, disabling, neurodegenerative disease characterised by three co...
Objective: Visual hallucinations are common in Parkinson’s disease (PD) and associated with worse ...
Parkinson’s disease (PD) is primarily associated with two dominant features: cardinal motor symptoms...
Background: Resting-state functional magnetic resonance imaging (fMRI) studies have demonstrated tha...
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder due to loss of dopamine produc...
Parkinson’s disease patients present with the highest risk of dementia development. The thalamus, i...